RecruitingNot ApplicableNCT04890821

Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System

Early Feasibility Study (EFS) of the Cardiac Implants Percutaneous Ring Annuloplasty System for the Treatment of Functional Tricuspid Regurgitation

Sponsor

Cardiac Implants LLC

Enrollment

15 participants

Start Date

Dec 1, 2021

Study Type

INTERVENTIONAL

Conditions

Tricuspid Regurgitation Functional

Summary

An early feasibility study to evaluate the safety and performance of 1) the transcatheter delivery and implantation of the Cardiac Implants (CI) annuloplasty ring and 2) the adjustment of the ring approximately 90 days following implantation in patients suffering from ≥ moderate functional tricuspid regurgitation (FTR).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called CI Percutaneous Ring Annuloplasty System for people with tricuspid regurgitation functional. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.